À¯¹æ¾ÏÀÇ Cyclin E ¹ßÇö°ú ÀÓ»ó¼Ò°ßÀÇ »ó°ü¼º ºÐ¼®
The Correlations between the Expression of Cyclin E and Clinical Features of the Primary Breast Cancer
¹ÚÀç¿ì, ¾ç±ÙÈ£, ¹èº´³ë, ±è±âȯ, ±èÈ«ÁÖ, ±è¿µ´ö, ±èÈ«¿ë, ¹Ú°æ¹Ì, ÇѼ¼È¯,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÀç¿ì ( Park Jae-Woo )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
¾ç±ÙÈ£ ( Yang Keun-Ho )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
¹èº´³ë ( Bae Byung-Noe )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±è±âȯ ( Kim Ki-Whan )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±èÈ«ÁÖ ( Kim Hong-Joo )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±è¿µ´ö ( Kim Young-Duck )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±èÈ«¿ë ( Kim Hong-Yong )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
¹Ú°æ¹Ì ( Park Kyeong-Mee )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø º´¸®Çб³½Ç
ÇѼ¼È¯ ( Han Se-Hwan )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
KMID : 0371320020630050372
Abstract
Purpose: Cyclin E is a key regulatory protein in the G1-S transition during the cell cycle. The correlations between cyclin E protein and the clinical features of breast cancer were investigated in order to evaluate its clinical utility
in
invasive breast cancer.
Methods: An immunohistochemical assay for cyclin E was performed in 101 consecutive invasive breast cancers. The correlation between cyclin E expression and the clinicobiological parameters including patient survival was analyzed.
Results: Cyclin E expression was observed in 50 patients (49.5%). The scoring of the cyclin E expression level was divided into low (£¼25%) and high (¡Ã25%). In high nuclear grade tumors, cyclin E overexpression was much higher than that in
low
nuclear grade tumors (P=0.049). In the younger age group (£¼50 yrs), cyclin E expression was significantly higher than the older age group (P=0.016). No significant correlation was observed between cyclin E and the tumor size, lymph node status,
hormonal receptor status, histological grade, mitotic index and Ki67. In multivariate analysis, only the lymph node status was significantly associated with the patients¡¯ outcome (P=0.002).
Conclusion: Cyclin E overexpression did not have prognostic impact on the patients¡¯ survival rate in invasive breast cancer. In high nuclear grade tumors, the cyclin E expression level was much higher. The definite value of cyclin E as a
clinicobiologic marker should be further investigated by prospective studies with other cell regulatory proteins.
Å°¿öµå
¼¼Æ÷Áõ½Ä; ¿¹ÈÄ; À¯¹æ¾Ï; ÇÙºÐȵµ; Cyclin E; Breast cancer; Cell proliferation; Cyclin E; Nuclear grade; Prognosis;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸